Recent studies showed that the activation of STING by c-di-GMP in infiltrated CD8+ T cells results in increased expression of PD-1 pathway components in multiple murine cancer types, including colon, tongue squamous carcinoma, pancreatic carcinoma and head and neck squamous cell carcinoma models [55, 90]. Here, STING1 is linked to cancer.